Thermo Fisher Scientific Inc. (TMO) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Thermo Fisher Scientific Inc. (TMO) stock forecast summary
Our AI ranks Thermo Fisher Scientific Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Thermo Fisher Scientific Inc. is a mega-cap company with a market capitalization of $255.13B. It ranks number 1 by market capitalization among the 11 Measuring & Controlling Devices, NEC issuers in our coverage with a current forecast. Its Net Margin of 15.0% is the highest of the 8 peers that report one.
For TMO, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 47.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 19.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, TMO included.
Follow TMO freeTMO price chart and AI forecast
How TMO ranks among 5172 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Thermo Fisher Scientific Inc. (TMO) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Measuring & Controlling Devices, NEC peers listed below that report each metric.
Valuation & Market
| Metric | TMO | Rank |
|---|---|---|
| Market Cap | $255.13B | 1/11 |
| P/E Ratio | 37.12x | 5/6 |
| P/B Ratio | 4.84x | 4/11 |
| Dividend Yield | 0.26% | – |
| EPS | $18.59 | – |
| Book Value/Share | $142.47 | – |
| Revenue/Share | $125.32 | – |
| FCF/Share | $19.79 | – |
Profitability & Margins
| Metric | TMO | Rank |
|---|---|---|
| ROE | 13.2% | 2/8 |
| ROA | 6.2% | 3/8 |
| ROIC | 8.3% | 3/9 |
| Operating Margin | 17.6% | 2/10 |
| Net Margin | 15.0% | 1/8 |
| EBT Margin | 16.4% | 1/10 |
| Tax Rate | 7.9% | – |
Financial Health
| Metric | TMO | Rank |
|---|---|---|
| Current Ratio | 1.55x | 6/9 |
| Quick Ratio | 1.18x | 6/9 |
| D/E Ratio | 1.15x | 4/11 |
| Financial Leverage | 2.15x | 4/11 |
| Interest Coverage | 1.4x | 5/9 |
| Working Capital | $8.30B | 1/9 |
Cash Flow
| Metric | TMO | Rank |
|---|---|---|
| Operating Cash Flow | $9.01B | 1/10 |
| Free Cash Flow | $7.32B | 1/8 |
| Capital Spending | -$1.70B | 8/8 |
| OCF Growth YoY | 18.9% | 4/5 |
| FCF Growth YoY | 18.6% | – |
| FCF/Sales | 15.8% | 3/8 |
| CapEx/Sales | 3.7% | 4/8 |
Operational Efficiency
| Metric | TMO | Rank |
|---|---|---|
| Asset Turnover | 0.41x | 6/8 |
| Receivables Turnover | 4.9x | 6/8 |
| Fixed Assets Turnover | 4.3x | 6/8 |
| Days Sales Outstanding | 74 days | 3/8 |
Income Statement
| Metric | TMO | Rank |
|---|---|---|
| Total Revenue | $46.34B | 1/8 |
| Operating Income | $8.15B | 1/10 |
| Net Income | $6.97B | 1/8 |
| R&D Expense | $1.40B | 1/10 |
| SG&A Expense | $9.03B | 1/10 |
Dividend & Shareholder Information
| Metric | TMO | Rank |
|---|---|---|
| Dividends Per Share | $1.79 | – |
| Payout Ratio | 9.6% | – |
| Shares Outstanding | 370M | – |
| Net Income Growth | 5.8% | – |
| EPS Growth | 7.5% | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $23.36B | 20.6% of assets |
| Cash & Short-term Investments | $4.06B | 3.6% of assets |
| Accounts Receivable | $9.45B | 8.4% of assets |
| Inventory | $5.63B | 5.0% of assets |
| Total Liabilities | $60.49B | 53.4% of assets |
| Short-term Debt | $11.80B | 10.4% of assets |
TMO quarterly financials and insider trading
Thermo Fisher Scientific Inc. (TMO) industry peers
Companies classified under the same SEC industry code as Thermo Fisher Scientific Inc. (Measuring & Controlling Devices, NEC): 11 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| TMO Thermo Fisher Scientific Inc. | ▼ | $255.13B |
| ROK Rockwell Automation, Inc | ▼ | $47.33B |
| TRMB Trimble Inc. | ▶ | $13.86B |
| ONTO Onto Innovation Inc. | ▲ | $10.83B |
| MIR Mirion Technologies, Inc. | ▶ | $3.47B |
| QSI Quantum-Si Inc | ▲ | $241M |
| OWLT Owlet, Inc. | ▲ | $120M |
| GEOS Geospace Technologies Corp | ▶ | $57M |
| AATC Autoscope Technologies Corp | ▼ | $32M |
| BCHT Birchtech Corp. | ▲ | $31M |
| NIKI Niki Biosolutions, Inc. | ▲ | $6M |
Where TMO sits on the market map
Thermo Fisher Scientific Inc. (TMO) stock news
Loading...
Thermo Fisher Scientific Inc. (TMO) stock forecast FAQ
What is the Thermo Fisher Scientific Inc. (TMO) stock forecast?
Our AI ranks Thermo Fisher Scientific Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Thermo Fisher Scientific Inc. stock predictions?
For TMO, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 47.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 19.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Thermo Fisher Scientific Inc. forecasts updated?
Thermo Fisher Scientific Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Thermo Fisher Scientific Inc.'s industry peers?
11 issuers in our coverage, TMO included, share the SEC industry code Measuring & Controlling Devices, NEC. The largest are: Rockwell Automation, Inc (ROK), Trimble Inc. (TRMB), Onto Innovation Inc. (ONTO), Mirion Technologies, Inc. (MIR), Quantum-Si Inc (QSI), Owlet, Inc. (OWLT).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.